Full chart
Key facts today
DexCom Inc. experienced a decline of 6.3% on Tuesday, contributing to the negative performance of major indices such as the S&P 500 and Nasdaq 100.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Market capitalization
29.19 BUSD
—
47.87
1.71USD
541.50 MUSD
3.62 BUSD
394.61 M
Beta (1Y)
0.87
About DexCom, Inc.
Sector
Industry
CEO
Kevin Ronald Sayer
Website
Headquarters
San Diego
Employees (FY)
9.6 K
Founded
1999
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
0.00
5 Shades of Grey!DXCM 5 shades of grey; First started in May 2020 when this area of around 107 continues tocomeback whether it be to consolidate, trend, or reverse 3 pivot points found, fast forward to the 2nd shade of grey when in February 2021 the stock came back as a double top. The 3rd shade started a year a
Long
11
DXCM, a broken stock? The stock is down 40% for three main reasons:Market Share Loss to Competitors: The company lost significant market share to NYSE:ABT in the Medical Device Channel (MDC), contributing about $100 million to the guide down.Slower New Patient Growth: There was a noticeable slowdown in new patient
Long
EPIC DROP in a Stable Company Top 5 thoughts-----1. has real cash 2. has low cost debt 3. has real customers 4. serves a need 5. The quarterly results in no way corresponds to the market sell off
Long
2 gaps to mid 70 analyst not going less than 80Downgrades galore, but not necessarily because of the results more as they are about what banks, analysts, and other were trying to get their head around less customer paid, and more areas to work on, however analsyts are not fazed by his. Plus reset the indicators and we are starting to find our bo
Long
6/24/24 - $dxcm - Caught attention but need $80s minimally6/24/24 :: VROCKSTAR :: NASDAQ:DXCM Caught attention but need $80s minimallybefore i started publishing my notes to myself a month and a half ago i had flagged this one after running thru several 13fs, this one showed up in Tiger's portfolio.my impression is "wow" great growth, useful product/
Long
22
DXCM could rally hereSeems like sitting on a nice support here. In a strong demand zone, sitting on POC as well. Insane volume, above 119 could fly. Also closed at the 10EMA, and we can see buying pressure. Stop loss for me would be 113.30. Risk to reward is there.
Long
Dexcom Plummets 10% on Raising Its Sales Guidance For The Year Dexcom ( NASDAQ:DXCM ) stock ended Friday's trading session on a rough slate despite the company's first-quarter beat and boosted sales guidance.Sales guidance, however, was light at the midpoint and Dexcom ( NASDAQ:DXCM ) stock plummeted 10%, closing at 124.34. easily boycotting a recent buy poin
Short
DXCM DexCom Options Ahead of EarningsAnalyzing the options chain and the chart patterns of DXCM DexCom prior to the earnings report this week,I would consider purchasing the 137usd strike price Calls withan expiration date of 2024-5-3,for a premium of approximately $5.95.If these options prove to be profitable prior to the earning
Long
DexCom with Growing FundsFundamentals: Develops glucose monitoring systems. This stock meets 80% of my parameters. I wouldn't have considered it if the earnings were not above 20%. I do not like the stability of the earnings and I do not like the trajectory of the earnings, though. However, I do like the accelerating sales
Long
DXCM - 28 months SYMMETRICAL TRIANGLE══════════════════════════════Since 2014, my markets approach is to spottrading opportunities based solely on thedevelopment ofCLASSICAL CHART PATTERNS🤝Let’s learn and grow together 🤝══════════════════════════════Hello Traders ✌After a careful consideration I came to the conclusion that:-
Long
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
The current price of
DXCM
is
73.20
USD
— it has increased by
0.48
% in the past 24 hours. Watch
DexCom, Inc.
stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on
NASDAQ
exchange
DexCom, Inc.
stocks are traded under the ticker
DXCM
.
DXCM
stock has risen by
3.98
% compared to the previous week, the month change is a
−35.08
% fall, over the last year
DexCom, Inc.
has showed a
−29.87
% decrease.
We've gathered analysts' opinions on
DexCom, Inc.
future price: according to them,
DXCM
price has a max estimate of
130.00
USD
and a min estimate of
75.00
USD
. Watch
DXCM chartand read a more detailed
DexCom, Inc. stock forecast: see what analysts think of
DexCom, Inc.
and suggest that you do with its stocks.
DXCM
reached its all-time high on
Nov 18, 2021
with the price of
164.86
USD
, and its all-time low was
0.34
USD
and was reached on
Nov 20, 2008
. View more price dynamics on
DXCM chart.
See other stocks reaching their highest and lowest prices.
DXCM
stock is
2.22
% volatile and has beta coefficient of
0.87
. Track
DexCom, Inc.
stock price on the chart and check out the list of the most volatile stocks — is
DexCom, Inc.
there?
Today
DexCom, Inc.
has the market capitalization of
29.19 B
, it has increased by
4.00
% over the last week.
Yes, you can track
DexCom, Inc. financialsin yearly and quarterly reports right on TradingView.
DexCom, Inc.
is going to release the next earnings report on
Oct 24, 2024
. Keep track of upcoming events with our Earnings Calendar.
DXCM
earnings for the last quarter are
0.43
USD
per share, whereas the estimation was
0.39
USD
resulting in a
11.35
% surprise. The estimated earnings for the next quarter are
0.44
USD
per share. See more details about
DexCom, Inc. earnings.
for the last quarter amounts to
1.00 B
USD
, despite the estimated figure of
1.04 B
USD
. In the next quarter, revenue is expected to reach
989.12 M
USD
.
DXCM
net income for the last quarter is
143.50 M
USD
, while the quarter before that showed
146.40 M
USD
of net income which accounts for
−1.98
% change. Track more
DexCom, Inc. financial statsto get the full picture.
No,
DXCM
doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of
Aug 22, 2024
, the company has
9.60 K
employees. See our rating of the largest employees — is
DexCom, Inc.
on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company.
DexCom, Inc.
EBITDA is
886.80 M
USD
, and current EBITDA margin is
21.64
%. See more stats in
DexCom, Inc. financial statements.
Like other stocks,
DXCM
shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade
DexCom, Inc.
stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So
DexCom, Inc.
technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating
DexCom, Inc.
stock shows the sell signal. See more of
DexCom, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
